FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apollo Care Fentanyl 500mcg Recall

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0

Apollo Care · Columbia, MO

Risk level
Class II
Reported by FDA
Apr 5, 2023
Recall ID
D-0487-2023
Check your lot numberHow we source this data

Summary

Apollo Care recalled Fentanyl 500mcg starting Feb 8, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0487-2023 on Apr 5, 2023. Reason: Lack of assurance of sterility: Suspected microbial growth present on external label packaging. Status: Ongoing.

Why it was recalled

Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

Product description

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25

Lot numbers, UPCs & expiration codes

Lot #: AC-016581

Where it was sold

MO

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0487-2023
Classification
Class II
Status
Ongoing
Recall initiated
Feb 8, 2023
FDA report date
Apr 5, 2023
Quantity
215 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Apollo Care

Original FDA data

Every field from FDA enforcement report D-0487-2023, exactly as published.

Show all FDA fields
City
Columbia
State
MO
Status
Ongoing
Country
United States
Event ID
91674
Address
3801 Mojave Ct Ste 101
Code information
Lot #: AC-016581
Postal code
65202-4042
Report date
Apr 5, 2023
Product type
Drugs
Recall number
D-0487-2023
Classification
Class II
Recalling firm
Apollo Care
Product quantity
215 bags
Reason for recall
Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25
Distribution pattern
MO
Recall initiation date
Feb 8, 2023
Initial firm notification
E-Mail
Center classification date
Mar 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0487-2023, published Apr 5, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls